Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$809M |
| 2 |
Apple
AAPL
|
+$675M |
| 3 |
Microsoft
MSFT
|
+$499M |
| 4 |
SPDR Gold Trust
GLD
|
+$433M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$486M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$464M |
| 3 |
Alibaba
BABA
|
+$412M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$336M |
| 5 |
RTX Corp
RTX
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.57% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.11% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Communication Services | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGP
3376
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $837K | ﹤0.01% |
31,553
-20,794
| -40% | -$566K |
|
|
TLRD
3377
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $837K | ﹤0.01% |
33,400
+4,500
| +16% | +$104K |
|
|
AVEO
3378
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $834K | ﹤0.01% |
28,750
-1,798
| -6% | -$52.6K |
|
|
REVG
3379
DELISTED
REV Group
REVG
| $833K | ﹤0.01% |
40,083
+22,064
| +122% | +$599K |
|
|
HEP
3380
DELISTED
Holly Energy Partners, L.P.
HEP
| $833K | ﹤0.01% |
30,183
+1,394
| +5% | +$42.5K |
|
|
NTRI
3381
DELISTED
NutriSystem, Inc.
NTRI
| $833K | ﹤0.01% |
30,887
+23,367
| +311% | +$930K |
|
3382
BBVA Argentina
BBAR
$3.48B
| $830K | ﹤0.01% |
36,400
-7,599
| -17% | -$182K |
|
3383
PUT
iShares MSCI Germany ETF
EWG
$1.62B
| $830K | ﹤0.01% |
25,900
+18,000
| +228% | +$599K |
|
|
FENG
3384
Phoenix New Media
FENG
$17.5M
| $830K | ﹤0.01% |
31,821
+1
| +0% | +$35 |
|
|
CVGW
3385
DELISTED
Calavo Growers
CVGW
| $829K | ﹤0.01% |
8,994
+2,052
| +30% | +$180K |
|
3386
CALL
TransDigm Group
TDG
$67.7B
| $829K | ﹤0.01% |
2,700
-6,000
| -69% | -$1.77M |
|
3387
Patrick Industries
PATK
$2.9B
| $828K | ﹤0.01% |
20,049
+14,271
| +247% | +$616K |
|
3388
CONMED
CNMD
$1.46B
| $827K | ﹤0.01% |
13,075
+4,782
| +58% | +$285K |
|
3389
Toro Company
TTC
$9.51B
| $827K | ﹤0.01% |
13,248
-57,708
| -81% | -$3.68M |
|
3390
Unilever
UL
$136B
| $827K | ﹤0.01% |
13,239
+947
| +8% | +$57.6K |
|
3391
CALL
Vanguard FTSE Europe ETF
VGK
$31.3B
| $826K | ﹤0.01% |
14,200
-92,000
| -87% | -$5.51M |
|
3392
Cavco Industries
CVCO
$4.53B
| $825K | ﹤0.01% |
4,745
-186
| -4% | -$30.7K |
|
3393
8x8 Inc
EGHT
$339M
| $824K | ﹤0.01% |
44,169
+29,622
| +204% | +$524K |
|
|
APU
3394
DELISTED
AmeriGas Partners, L.P.
APU
| $824K | ﹤0.01% |
20,596
-388
| -2% | -$17.2K |
|
3395
CALL
Chemours
CC
$2.42B
| $823K | ﹤0.01% |
16,900
+14,000
| +483% | +$700K |
|
3396
PUT
Exelon
EXC
$47.2B
| $823K | ﹤0.01% |
29,582
-38,275
| -56% | -$1.03M |
|
3397
Matador Resources
MTDR
$6.16B
| $822K | ﹤0.01% |
27,506
+7,863
| +40% | +$239K |
|
3398
Valley National Bancorp
VLY
$8.03B
| $822K | ﹤0.01% |
65,935
+4,791
| +8% | +$59.7K |
|
|
LGF.B
3399
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $822K | ﹤0.01% |
34,143
+11,876
| +53% | +$341K |
|
|
ACGN
3400
DELISTED
Aceragen Inc
ACGN
| $821K | ﹤0.01% |
3,285
+3,075
| +1,464% | +$844K |
|
Similar funds
Barclays's Q1 2018 Portfolio in Review
As of Q1 2018, Barclays held 7,683 positions worth $131B, up 6.9% from $122B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $8.37B of net new capital in Q1 2018, opening 561 new positions and adding to 3,709 existing holdings. Its largest new stake was Invesco KBW Bank ETF: 755,000 shares worth $41.5M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $486M trimmed.
- Barclays's largest Q1 2018 buy was Invesco KBW Bank ETF: 755,000 shares worth $41.5M.
- Barclays added most to iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2018, an estimated $809M increase.
- Barclays's biggest Q1 2018 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $486M.
- Barclays fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $53.4M.
- Barclays's ten largest holdings make up 25% of its $131B portfolio in Q1 2018.
- Barclays opened 561 new positions and closed 395 in Q1 2018.
- Barclays's portfolio value rose 6.9% quarter-over-quarter to $131B.
Based on Barclays's 13F filing for Q1 2018, filed 15 May 2018.